Optimizing rotational atherectomy in high-risk percutaneous coronary interventions: Insights from the PROTECT ΙΙ study

Catheterization and Cardiovascular Interventions

Volumn 83, Issue 7, 2014, Pages 1057-1064

  Cohen, Mauricio G ^a   Ghatak, Abhijit ^a   Kleiman, Neal S ^b   Naidu, Srihari S ^c   Massaro, Joseph M ^d   Kirtane, Ajay J ^e   Moses, Jeffrey ^e   Magnus Ohman, E ^f   Džavík, Vladimír ^g   Palacios, Igor F ^h   Heldman, Alan W ^a   Popma, Jeffrey J ⁱ   O'Neill, William W ^j  

^a UNIVERSITY OF MIAMI HOSPITAL   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^c WINTHROP UNIVERSITY HOSPITAL   (United States)

^d HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^e NewYork Presbyterian Hospital   (United States)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

^g UNIVERSITY HEALTH NETWORK   (Canada)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j HENRY FORD HOSPITAL   (United States)

more..

Author keywords

atherectomy; percutaneous coronary intervention; ventricular support device

Indexed keywords

CREATINE KINASE MB;

AGE DISTRIBUTION; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CARDIOVASCULAR MORTALITY; COMORBIDITY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY DISEASE; CORONARY ARTERY OCCLUSION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEART HEMODYNAMICS; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART OUTPUT; HUMAN; INCIDENCE; INTRAAORTIC BALLOON PUMP; LEFT VENTRICULAR ASSIST DEVICE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; PATIENT HISTORY OF SURGERY; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PROCESS OPTIMIZATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); ROTATIONAL ATHERECTOMY; SOCIETY OF THORACIC SURGEONS PREDICTED RISK OF MORTALITY SCORE; SYNERGY BETWEEN PCI WITH TAXUS AND CARDIAC SURGERY SCORE; TREATMENT DURATION; ATHERECTOMY; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY ARTERY BLOOD FLOW; EPIDEMIOLOGY; FOLLOW UP; MULTICENTER STUDY; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PLAQUE, ATHEROSCLEROTIC; PROCEDURES; PROSPECTIVE STUDY; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TIME; TREATMENT OUTCOME; UNITED STATES;

AGED; ATHERECTOMY, CORONARY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PLAQUE, ATHEROSCLEROTIC; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84901018866     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25277     Document Type: Article

References (28)

1. Brogan WC, III, Popma JJ, Pichard AD, et al. Rotational coronary atherectomy after unsuccessful coronary balloon angioplasty. Am J Cardiol 1993; 71: 794-798.
2. Warth DC, Leon MB, O'Neill W, Zacca N, Polissar NL, Buchbinder M,. Rotational atherectomy multicenter registry: Acute results, complications and 6-month angiographic follow-up in 709 patients. J Am Coll Cardiol 1994; 24: 641-648.
3. Moussa I, Di Mario C, Moses J, et al. Coronary stenting after rotational atherectomy in calcified and complex lesions. Angiographic and clinical follow-up results. Circulation 1997; 96: 128-136.
4. Vaquerizo B, Serra A, Miranda F, et al. Aggressive plaque modification with rotational atherectomy and/or cutting balloon before drug-eluting stent implantation for the treatment of calcified coronary lesions. J Interv Cardiol 2010; 23: 240-248.
5. Curtis JP, Rathore SS, Wang Y, Chen J, Nallamothu BK, Krumholz HM,. Use and effectiveness of intra-aortic balloon pumps among patients undergoing high risk percutaneous coronary intervention: insights from the National Cardiovascular Data Registry. Circ Cardiovasc Qual Outcomes 2012; 5: 21-30.
6. Henriques JP, Remmelink M, Baan J, Jr., et al. Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5. Am J Cardiol 2006; 97: 990-992.
7. Maini B, Naidu SS, Mulukutla S, et al. Real-world use of the impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: The uspella registry. Catheter Cardiovasc Interv 2012; 80: 717-725.
8. Dixon SR, Henriques JP, Mauri L, et al. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): Initial U.S. experience. JACC Cardiovasc Interv 2009; 2: 91-96.
9. O'Neill WW, Kleiman NS, Moses J, et al. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation 2012; 126: 1717-1727.
10. Sianos G, Morel MA, Kappetein AP, et al. The SYNTAX Score: An angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005; 1: 219-227.
11. Popma JJ, Moses J, Kleiman N, et al. Impella improves clinical outcomes when extensive revascularization is performed: The PROTECT II Study. J Am Coll Cardiol 2012; 59 (Supplement): E1522.
12. Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization. Task Force on Myocardial Revascularization of the European Society of, Cardiology the European Association for Cardio-Thoracic, Surgery European Association for Percutaneous Cardiovascular, Interventions. Eur Heart J. 2010; 31: 2501-2555.
13. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 2011; 124: e574-e651.
14. Williams MJ, Dow CJ, Newell JB, Palacios IF, Picard MH,. Prevalence and timing of regional myocardial dysfunction after rotational coronary atherectomy. J Am Coll Cardiol 1996; 28: 861-869.
15. Safian RD, Niazi KA, Strzelecki M, et al. Detailed angiographic analysis of high-speed mechanical rotational atherectomy in human coronary arteries. Circulation 1993; 88: 961-968.
16. O'Murchu B, Foreman RD, Shaw RE, Brown DL, Peterson KL, Buchbinder M,. Role of intraaortic balloon pump counterpulsation in high risk coronary rotational atherectomy. J Am Coll Cardiol 1995; 26: 1270-1275.
17. Abdel-Wahab M, Baev R, Dieker P, et al. Long-term clinical outcome of rotational atherectomy followed by drug-eluting stent implantation in complex calcified coronary lesions. Catheter Cardiovasc Interv 2012; 81: 285-291.
18. Burkhoff D, Naidu SS,. The science behind percutaneous hemodynamic support: A review and comparison of support strategies. Catheter Cardiovasc Interv 2012; 80: 816-829.
19. Naidu SS,. Novel percutaneous cardiac assist devices: The science of and indications for hemodynamic support. Circulation 2011; 123: 533-543.
20. Cavusoglu E, Kini AS, Marmur JD, Sharma SK,. Current status of rotational atherectomy. Catheter Cardiovasc Interv 2004; 62: 485-498.
21. Abdelmeguid AE, Topol EJ, Whitlow PL, Sapp SK, Ellis SG,. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation 1996; 94: 1528-1536.
22. Kong TQ, Davidson CJ, Meyers SN, Tauke JT, Parker MA, Bonow RO,. Prognostic implication of creatine kinase elevation following elective coronary artery interventions. JAMA 1997; 277: 461-466.
23. Pervaiz MH, Sood P, Sudhir K, et al. Periprocedural myocardial infarction in a randomized trial of everolimus-eluting and Paclitaxel-eluting coronary stents: Frequency and impact on mortality according to historic versus universal definitions. Circ Cardiovasc Interv 2012; 5: 150-156.
24. Herrmann J,. Peri-procedural myocardial injury: 2005 update. Eur Heart J 2005; 26: 2493-519.
25. Cutlip DE, Kuntz RE,. Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Cardiac enzyme elevation after successful percutaneous coronary intervention is not an independent predictor of adverse outcomes. Circulation 2005; 112: 916-922; discussion 922.
26. Novack V, Pencina M, Cohen DJ, et al. Troponin criteria for myocardial infarction after percutaneous coronary intervention. Arch Intern Med 2012; 172: 502-508.
27. Stone GW, Mehran R, Dangas G, Lansky AJ, Kornowski R, Leon MB,. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: A device-specific analysis of 7147 patients. Circulation 2001; 104: 642-647.
28. Leonardi S, Thomas L, Neely ML, et al. Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction. J Am Coll Cardiol 2012; 60: 2296-2304.